The efficacy of selective serotonin reuptake inhibitors in adult social anxiety disorder: a meta-analysis of double-blind, placebo-controlled trials
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Social anxiety disorder is associated with impairment in social and occupational functioning, significant personal distress and a possible economic burden, resulting in a reduction in quality of life. To understand better the efficacy of selective serotonin reuptake inhibitors in social anxiety disorder, randomized, double-blind, placebo-controlled trials were evaluated. Pubmed and PsychINFO electronic databases were searched for social anxiety disorder, social phobia, selective serotonin reuptake inhibitors, citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine and sertraline. Fifteen published, randomized, double-blind, placebo-controlled trials of selective serotonin reuptake inhibitors in social anxiety disorder were identified. Design, subject number, drug and dose, trial length, rating instruments, and baseline and end point data were extracted and then verified independently by a second investigator. Effect sizes were calculated from mean changes in drug and placebo groups in the Liebowitz Social Anxiety Scale and the Sheehan Disability Scale, as well as from other scales where available. For the binary data of the Clinical Global Impression of Change scores, Θlog-odds ratios (the effect-size measure appropriate for binary data) were calculated from proportion changes. Effect sizes for the Liebowitz Social Anxiety Scale ranged from -0.029 to 1.214. Effect sizes for the Sheehan Disability Scale ranged from 0.203 to 0.480 for work, 0.237 to 0.786 for social function, and 0.118 to 0.445 for family function. ΘThe log-odds ratios for Clinical Global Impression of Change scores ranged from 0.644 to 3.267. Consistent with previous studies, selective serotonin reuptake inhibitors appear more effective than placebo for social anxiety disorder, with improvement extending into social and occupational function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brief standard self-rating for phobic patients
Marks, I. M., & Mathews, A. M. (1979) · Behaviour Research and Therapy · doi:10.1016/0005-7967(79)90041-x · Cited by 1,801
Psychometric properties of the Liebowitz Social Anxiety Scale
HEIMBERG, R. G., HORNER, K. J., JUSTER, H. R., SAFREN, S. A., BROWN, E. J., SCHNEIER, F. R., & LIEBOWITZ, M. R. (1999) · Psychological Medicine · doi:10.1017/s0033291798007879 · Cited by 968
Meta‐Analysis Of Controlled Clinical Trials
Whitehead, A. (2002) · doi:10.1002/0470854200 · Cited by 827
Fluoxetine, Comprehensive Cognitive Behavioral Therapy, and Placeboin Generalized Social Phobia
Davidson, J. R. T., Foa, E. B., Huppert, J. D., Keefe, F. J., Franklin, M. E., Compton, J. S., Zhao, N., Connor, K. M., Lynch, T. R., & Gadde, K. M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.10.1005 · Cited by 415
Lader, M., Stender, K., Bürger, V., & Nil, R. (2004) · Depression and Anxiety · doi:10.1002/da.20014 · Cited by 163 · cited 12×
“…Impression of Improvement data based upon log-odds ratios (using combined data from the Liebowitz et al. (2002) and Lader et al. (2004) studies and not data from the individual fixed doses) was 1.016 (95% confidence interval 0.851–1.182) not including the 24 week data from Lader et al. (2004).”
BackgroundMethodResultInfluentialvan der Linden, G. J., Stein, D. J., & van Balkom, A. J. (2000) · International Clinical Psychopharmacology · doi:10.1097/00004850-200008002-00004 · Cited by 130
Pharmacotherapy of social anxiety disorder
Blanco, C., Antia, S. X., & Liebowitz, M. R. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01294-x · Cited by 88 · cited 7×
“Consistent with previously reported analyses (van der Linden et al., 2000; Blanco et al., 2002; Blanco et al., 2003), the current findings indicate that selective serotonin reuptake inhibitors paroxetine, sertraline, fluvoxamine, fluoxetine and escitalopram are more efficacious than placebo for the…”
BackgroundResultInfluential
Research works printed but not linked: 29
- 10.1111/j.1600-0447.1999.tb10845.x · DOI · Paper page
- 10.1192/bjp.175.2.120 · DOI · Paper page
- 10.1017/S1461145703003791 · DOI · Paper page
- 10.1192/bjp.179.1.23 · DOI · Paper page
- 10.1017/S0033291796004217 · DOI · Paper page
- 10.1097/00004714-199312000-00008 · DOI · Paper page
- 10.1097/01.jcp.0000106222.36344.96 · DOI · Paper page
- 10.1002/(SICI)1520-6394(1996)4:5<223::AID-DA3>3.0.CO;2-E · DOI
- 10.1016/S0006-3223(97)86966-1 · DOI
- Guy W (1976) ECDEU assessment manual for psychopharmacology. US Department of Health, Education and Welfare Publication (ADM) 76-338. National Institute of Mental Health, Rockville, MD , pp. 218-222
- 10.1111/j.2044-8341.1959.tb00467.x · DOI · Paper page
- 10.1136/jnnp.23.1.56 · DOI · Paper page
- Hedges L V, 1985, Statistical Methods for Meta-Analysis
- Judd L L, 1994, J Clin Psychiatry, 55, 5
- 10.1176/ajp.152.9.1368 · DOI · Paper page
- 10.1001/archpsyc.1994.03950010008002 · DOI · Paper page
- 10.1097/00004714-200206000-00005 · DOI · Paper page
- 10.4088/JCP.v65n0213 · DOI · Paper page
- 10.4088/JCP.v63n0113 · DOI · Paper page
- 10.4088/JCP.v64n0708 · DOI · Paper page
- 10.1192/bjp.134.4.382 · DOI · Paper page
- Shear M K, 1998, J Clin Psychiatry, 59, 39
- Sheehan D V, 1983, The Anxiety Disease
- Stein M B, 1999, Am J Psychiatry, 156, 756, 10.1176/ajp.156.5.756 · DOI · Paper page
- 10.1001/jama.280.8.708 · DOI · Paper page
- 10.1345/aph.1D172 · DOI · Paper page
- 10.1176/appi.ajp.158.2.275 · DOI · Paper page
- 10.1007/BF02244762 · DOI · Paper page
- 10.1037/h0027806 · DOI · Paper page
Cited by
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
“Antidepressants: Meta-analyses demonstrate that SSRIs and SNRIs are significantly more effective than placebo [58,426-429] and RIMAs [426,428] for the treatment of SAD.”
BackgroundAndrews, G., Bell, C., Boyce, P., Gale, C., Lampe, L., Marwat, O., Rapee, R., & Wilkins, G. (2018) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867418799453 · Cited by 243
“A metaanalysis of placebo-controlled RCTs assessing the efficacy of SSRIs in SAD (Hedges et al., 2007) reported that there was no evidence for a dose–response relationship in studies that compared different doses, but the authors concluded that the answer was not yet clear.”
BackgroundMethodObsessive-Compulsive and Related Disorders: A Critical Review of the New Diagnostic Class
Abramowitz, J. S., & Jacoby, R. J. (2015) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032813-153713 · Cited by 185
“Numerous RCTs demonstrate that SSRIs are efficacious in the treatment of problems other than the OCRDs, including unipolar depressive disorders (e.g., Fournier et al. 2010, Schatzberg & Nemeroff 2013) and anxiety disorders such as social anxiety disorder (Hedges et al. 2007).”
BackgroundPharmacotherapy of anxiety disorders: A critical review
Koen, N., & Stein, D. J. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.4/nkoen · Cited by 151
Anxiety disorders: a comprehensive review of pharmacotherapies
Hoffman, E. J., & Mathew, S. J. (2008) · Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20041 · Cited by 149
Metadata
- Authors
- Hedges, D. W., Brown, B. L., Shwalb, D. A., Godfrey, K., & Larcher, A. M.
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2007-01
- Volume
- 21
- Issue
- 1
- Pages
- 102-111
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2086554590
- Cited by
- 83
- References
- 7
- FWCI
- 1.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The efficacy of selective serotonin reuptake inhibitors in adult social anxiety disorder: a meta-analysis of double-blind, placebo-controlled trials. https://app.cochat.ai/papers/10.1177/0269881106065102
- The paper
- Hedges, D. W., Brown, B. L., Shwalb, D. A., Godfrey, K., & Larcher, A. M. (2007). The efficacy of selective serotonin reuptake inhibitors in adult social anxiety disorder: a meta-analysis of double-blind, placebo-controlled trials. Journal of Psychopharmacology. https://doi.org/10.1177/0269881106065102
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.